Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657667 · ClinicalTrials.gov registry record · NA
Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones
A NA study, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03657667: Completed NA study, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
NCT03657667 is a NA study that has completed, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657667, a NA study, has completed, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
Pain associated with renal stone disease is typically caused by an obstructing stone that obstructs the flow of urine, which results in renal collecting system dilatation. Non-obstructing renal calculi that do not cause renal collecting system dilatation are thought to be painless. The objective of this study is to prospectively determine if the removal of non-obstructing renal calculi can reduce or eliminate participant's pain and/or improve their quality of life.
Primary Outcome
evaluated using The Brief Pain Inventory; scale from 0-10; worst pain is 10
Interventions
- PROCEDURE Ureteroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2023-03-09 |
| Phase | NA |
What the finished NCT03657667 record still lists
NCT03657667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Ureteroscopy is the first listed.
NCT03657667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03657667 about?
NCT03657667 is a clinical study titled "Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones". Pain associated with renal stone disease is typically caused by an obstructing stone that obstructs the flow of urine, which results in renal collecting system dilatation. Non-obstructing renal calculi that do not cause renal collecting system dilatation are thought to be painless. The objective of ...
What is the current status of trial NCT03657667?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-08-28. Estimated completion is 2023-03-09.
What interventions are being tested in trial NCT03657667?
The interventions under investigation include: Ureteroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03657667?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03657667's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI